Autopsy report · NCT02045030

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Drug (Aflibercept) no longuer available for the study”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 2 years 10 months before it stopped.
14 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: CR-CSSS Champlain-Charles-Le Moyne
Sponsor type: University, hospital or other
Conditions: Metastatic Colorectal Cancer
Interventions: aflibercept + FOLFIRI
Participants: 14
Sites: 4
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.